The Truth About Cholesterol — A 2026 Perspective
TL;DR
The 2013 article was ahead of its time in highlighting inflammation and lifestyle as key drivers of heart disease. In 2026, the picture is more integrated: LDL/apoB lowering still saves lives and remains the primary strategy for high‑risk individuals, while inflammation explains residual risk and is now targeted through lifestyle, low‑dose colchicine, and emerging IL‑6 therapies. For individuals: focus on anti-inflammatory habits, get full risk assessment (LDL/apoB + hsCRP + imaging), and follow personalized medical advice. Cholesterol still matters — inflammation is the new layer on top.
Back in 2013, this article argued that cholesterol alone wasn’t the full story behind heart disease — that inflammation, diet, and metabolic stress were major drivers. At the time, that view was ahead of the curve. A decade later, leading voices like Eric Topol and major cardiology societies now echo the same theme:
- atherosclerosis is both a lipid-driven and inflammation-driven disease.
But the 2026 reality is more nuanced than simply “cholesterol doesn’t matter.”
The modern understanding is this:
- Lowering LDL/apoB still saves lives and remains the foundation of prevention.
- Inflammation is the second layer — the part that explains residual risk.
What We Know in 2026
1. LDL / apoB lowering remains essential
Large clinical trials continue to show that reducing LDL and apoB reduces heart attacks, strokes, and cardiovascular death.
This is especially true for people with:
- family history
- diabetes
- high coronary calcium
- prior cardiovascular events
The old “cholesterol is irrelevant” narrative simply doesn’t hold up.
2. Inflammation explains what cholesterol alone cannot
Even when LDL is well-controlled, many people still experience cardiovascular events.
This “residual risk” is strongly linked to chronic inflammation, measurable through markers like hsCRP.
This is why modern prevention includes:
- low-dose colchicine (now widely used)
- IL‑6–targeting therapies (emerging)
- anti-inflammatory lifestyle patterns
- metabolic health optimization
Inflammation doesn’t replace cholesterol — it adds to the picture.
3. The 2013 article’s lifestyle message still holds true
The original post emphasized:
- whole foods
- reduced sugar and processed foods
- stress reduction
- sleep
- movement
These remain foundational.
Lifestyle is the universal intervention that improves both lipids and inflammation.
What Individuals Should Do (General Guidance)
This is not medical advice — just the modern framework clinicians use.
✔Adopt an anti-inflammatory lifestyle
- Whole foods, fiber, omega‑3s, stable blood sugar, stress management.
✔Get a comprehensive risk assessment
- LDL, apoB, hsCRP, and imaging (like CAC) when appropriate.
✔Follow personalized medical guidance
- Because risk varies dramatically from person to person.
The truth about cholesterol isn’t that it’s irrelevant —
it’s that cholesterol and inflammation are two halves of the same story.
References
- Chan, K., Wahome, E., & Antoniades, C. (on behalf of the ORFAN Consortium). (2024). Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: The ORFAN multicentre, longitudinal cohort study. The Lancet, 403(10444), 2606–2618.
- This demonstrates dramatically elevated cardiac mortality risk from coronary inflammation detected via perivascular FAI Score on CCTA, even without obstructive CAD—up to ~30-fold with three inflamed arteries.)
- Mensah, G. A., et al. (2025). Inflammation and cardiovascular disease: 2025 ACC scientific statement: A report of the American College of Cardiology. Journal of the American College of Cardiology. Advance online publication. (PMID: 41020749)
- Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., ... & CANTOS Trial Group. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease. New England Journal of Medicine, 377(12), 1119–1131. (CANTOS trial—IL-1β inhibition)
- Ridker, P. M., et al. (2026). Rationale, design, and baseline clinical characteristics of the Ziltivekimab cardiovascular outcomes trial: Interleukin-6 inhibition and atherosclerotic event rate reduction. JAMA Cardiology, 11(1), 89–97. (ZEUS trial design—IL-6 inhibition with ziltivekimab in ASCVD + CKD)
- Ridker, P. M. (2021). From RESCUE to ZEUS: Will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction? European Heart Journal, 42(42), 4285–4287. (Background on ziltivekimab)
- Occhipinti, G., et al. (2025). Inflammation in coronary atherosclerosis: Diagnosis and therapeutic implications. (PMID: 40139681)
- Davison, B. A., et al. (2025). Effects of anti-inflammatory therapy in acute heart failure. (PMID: 39939545)
- Riksen, N. P., et al. (2026). Trained immunity in cardiovascular disease. European Heart Journal, 47(10), 1159–1170. (PMID: 41330410)
- The Truth About Heart Disease & Cholesterol — Dwight Lundell
- The Healthy Home by Dave Wentz and Dr. Myron Wentz
- Every patient is different, and every case of heart disease involves a multitude of factors, from diet to activity level to lifestyle, as well as the genetic diversity of the human race.
- U. Erasmus, Fats That Heal, Fats That Kill (Burnaby BC, Canada: Alive Books, 1993).
- Hanukoglu I (Dec 1992). "Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis.". J Steroid Biochem Mol Biol 43 (8): 779–804.
- U. Ravnskov, "High Cholesterol May Protect Against Infections and Atherosclerosis," QJM Internaltional Journal of Medicine 96 (2003): 927-34.
- Cholesterol (Wikipedia)
- Smith LL (1991). "Another cholesterol hypothesis: cholesterol as antioxidant". Free Radic. Biol. Med. 11 (1): 47–61.
- Western Diets and Western Diseases (Travel and Health)
- Omega-3 Fatty Acids (Travel and Health)
- 10 Things You Didn't Know About Cholesterol (Everyday Health)
- Check out "Pathology of Atherosclerotic Plaque" of this article
- David Seaman: Inflammation From Our Diet Is Killing Us Slowly (a must-watch video)
- Statin Drugs and Diabetes
- Statin drugs can increase women's risk of diabetes by 48%
- The Little-Known Vitamin Essential to Your Health
- Vitamin K2 deficiency can cause calcium-buildup, which can increase the risk of calcification of the arteries and hence the heart disease.
- High Cholesterol Tied to Prostate Cancer's Return in Study
- But expert doesn't recommend taking statins to prevent recurrence
- The Real Cause of Heart Disease
- The Overlooked Health Risks of Very Low Cholesterol
- New Scientific Analysis Confirms Saturated Fats Have No Link to Heart Disease
- The incredible cholesterol-lowering benefits of the Avocado
- Bad Cholesterol Not As Bad As People Think, Study Shows (TAMU)
- Flaxseed dietary fibers lower cholesterol and increase fecal fat excretion, but magnitude of effect depend on food type
- Research has shown that consuming flaxseed daily can help to reduce bad cholesterol.
- Deep Vein Thrombosis (DVT)
- Anything that damages the inner lining of a vein may cause DVT -- surgery, an injury, or your immune system.
- People who have certain genetic disorders or more estrogen in their system are more likely to have blood clots, too.
- Higher levels of estrogen during pregnancy may make blood clot more easily
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- Heart attack symptoms: Know what's a medical emergency
- Novartis Drug Becomes First To Prevent Heart Attacks And Strokes By Targeting Inflammation
- The Cholesterol Myth Has Been Busted — Yet Again
- Rethinking good cholesterol — A high HDL cholesterol level may not be as beneficial as once believed.
- The best food for high cholesterol (Dr Michael Greger)
- Oxidized Cholesterol as a Cause of Alzheimer’s Disease
- Low Fat Diet Associated With Reduced Testosterone Levels
- Chest Pain: 3 Signs It’s Not a Heart Attack and Possible Causes
- Wang B, Liu J, Chen S, Ying M, Chen G, Liu L, et al. Malnutrition affects cholesterol paradox in coronary artery disease: a 41,229 chinese cohort study. Lipids Health Dis. (2021) 20:36.
- Can High Cholesterol Cause Headaches?
- Is It Better to Drink Little Alcohol Than None? Do Any Benefits of Alcohol Outweigh the Risks?
- Acute phase reaction and acute phase proteins
- C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke
- What are blood clots and what causes them?
- Association Between γ′ Fibrinogen Levels and Inflammation
- Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19
- Weighing the Risks and Benefits of Statins (Michael Greger, M.D.)

Comments
Post a Comment